Last updated on June 2019

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)


Brief description of study

This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD. The goal is to prevent vision loss by evaluating the effectiveness of ONS-5010 as compared with ranibizumab.

Clinical Study Identifier: NCT03844074

Find a site near you

Start Over

Clinical Site

Hurstville, Australia
  Connect »

Clinical Site

Liverpool, Australia
  Connect »

Clinical Site

Sydney, Australia
  Connect »

Clinical Site

Westmead, Australia
  Connect »

Clinical Site

Brisbane, Australia
  Connect »

Clinical Site

Adelaide, Australia
  Connect »

Clinical Site

Hobart, Australia
  Connect »

Clinical Site

Essendon, Australia
  Connect »

Clinical Site

Glen Waverley, Australia
  Connect »